In 2022, the global orthopedic bone graft substitutes (BGS) market was valued at approximately $2 billion. Compared to 2022, the market was valued at slightly under $2 billion in 2021 because of COVID-19. In spite of this, the global orthopedic bone graft substitute market is expected to reach $2.7 billion by 2029. In seven years,
Orthopedic Bone Graft Substitutes: The Global Market Over the Next 7 Years
